apomorphine has been researched along with melatonin in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (27.27) | 18.7374 |
| 1990's | 4 (18.18) | 18.2507 |
| 2000's | 7 (31.82) | 29.6817 |
| 2010's | 5 (22.73) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Koulu, M; Lammintausta, R | 1 |
| Durlach-Misteli, C; Van Ree, JM | 1 |
| Burton, S; Daya, S; Potgieter, B | 1 |
| Iuvone, PM; Zawilska, J | 1 |
| Dubocovich, ML | 1 |
| Gaffori, O; Van Ree, JM | 2 |
| Guyda, H; Hariharasubramanian, N; Isaac, I; Lal, S; Nair, NP; Pilapil, C; Quirion, R | 1 |
| Niles, LP; Tenn, CC | 1 |
| al-Zadjali, KH; Imler, MP; Ohia, SE | 1 |
| Dabbeni-Sala, F; Franceschini, D; Giusti, P; Skaper, SD | 1 |
| Mandel, S; Weinreb, O; Youdim, MB | 2 |
| Abílio, VC; Duarte, CR; Ferreira, LS; Frussa-Filho, R; Martins, CR; Ribeiro, Rde A; Torres-Leite, D; Vera, JA | 1 |
| Byers, DM; Del Val, S; Irwin, LN; Moss, DE; Sumaya, IC | 1 |
| McMillan, CR; Niles, LP; Sharma, R; Tenn, CC | 1 |
| Binfaré, RW; Budni, J; Mantovani, M; Rodrigues, AL; Santos, AR | 1 |
| Du, Y; Lin, L; Lin, X; Shen, J; Yuan, S; Zheng, Z | 1 |
| Domínguez-López, S; Gobbi, G; Howell, RD; Leyton, M; López-Canúl, MG | 1 |
| Butenko, GM; Kopjak, BS; Kyzminova, IA; Labunets, IF; Podjachenko, EV; Rodnichenko, AE; Sagach, VF; Talanov, SA; Utko, NA; Vasilyev, RG | 1 |
2 trial(s) available for apomorphine and melatonin
| Article | Year |
|---|---|
Effect of melatonin on L-tryptophan- and apomorphine-stimulated growth hormone secretion in man.
Topics: Adult; Apomorphine; Growth Hormone; Humans; Male; Melatonin; Tryptophan | 1979 |
Effect of apomorphine on melatonin secretion in normal subjects.
Topics: Adolescent; Adult; Apomorphine; Circadian Rhythm; Growth Hormone; Humans; Male; Melatonin; Receptors, Dopamine | 1987 |
20 other study(ies) available for apomorphine and melatonin
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Dopamine and melatonin in the nucleus accumbens may be implicated in the mode of action of antidepressant drugs.
Topics: Animals; Antidepressive Agents; Apomorphine; Behavior, Animal; Desipramine; Dopamine; Dose-Response Relationship, Drug; Fluvoxamine; Male; Melatonin; Mianserin; Neurotransmitter Uptake Inhibitors; Nucleus Accumbens; Rats; Rats, Wistar; Receptors, Dopamine; Sensitivity and Specificity | 1992 |
Melatonin modulates apomorphine-induced rotational behaviour.
Topics: Animals; Apomorphine; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Huntington Disease; Hydroxydopamines; Male; Melatonin; Motor Activity; Oxidopamine; Parkinson Disease, Secondary; Quinolinic Acid; Quinolinic Acids; Rats; Rats, Inbred Strains | 1991 |
Catecholamine receptors regulating serotonin N-acetyltransferase activity and melatonin content of chicken retina and pineal gland: D2-dopamine receptors in retina and alpha-2 adrenergic receptors in pineal gland.
Topics: Acetyltransferases; Adrenergic beta-Antagonists; Animals; Apomorphine; Arylamine N-Acetyltransferase; Chickens; Clonidine; Darkness; Dopamine Antagonists; Light; Male; Melatonin; Pineal Gland; Receptors, Adrenergic, beta; Receptors, Dopamine; Receptors, Dopamine D2; Reference Values; Retina; Spiperone; Yohimbine | 1989 |
Luzindole (N-0774): a novel melatonin receptor antagonist.
Topics: Animals; Apomorphine; Binding, Competitive; Calcium; Clonidine; Dopamine; Electric Stimulation; Melatonin; Rabbits; Receptors, Melatonin; Receptors, Neurotransmitter; Retina; Tryptamines | 1988 |
Serotonin and antidepressant drugs antagonize melatonin-induced behavioural changes after injection into the nucleus accumbens of rats.
Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Apomorphine; Behavior, Animal; Grooming; Injections; Male; Melatonin; Motor Activity; Nucleus Accumbens; Rats; Rats, Inbred Strains; Serotonin; Serotonin Antagonists; Time Factors; Zimeldine | 1985 |
Beta-endorphin-(10-16) antagonizes behavioral responses elicited by melatonin following injection into the nucleus accumbens of rats.
Topics: Animals; Antidepressive Agents; Apomorphine; Behavior, Animal; beta-Endorphin; Endorphins; Male; Melatonin; Motor Activity; Nucleus Accumbens; Peptide Fragments; Rats; Rats, Inbred Strains; Septal Nuclei | 1985 |
Central-type benzodiazepine receptors mediate the antidopaminergic effect of clonazepam and melatonin in 6-hydroxydopamine lesioned rats: involvement of a GABAergic mechanism.
Topics: Animals; Apomorphine; Behavior, Animal; Bicuculline; Clonazepam; Corpus Striatum; Dopamine Agonists; Flumazenil; Flunitrazepam; gamma-Aminobutyric Acid; Isoquinolines; Male; Melatonin; Oxidopamine; Rats; Rats, Sprague-Dawley; Receptors, GABA-A | 1995 |
Inhibitory effect of prostaglandins on dopamine release from the retina.
Topics: Animals; Apomorphine; Cyclooxygenase Inhibitors; Dinoprostone; Dopamine; Electric Stimulation; Flurbiprofen; In Vitro Techniques; Male; Melatonin; Prostaglandin Antagonists; Prostaglandins; Rabbits; Receptors, Cell Surface; Receptors, Dopamine D2; Receptors, Melatonin; Receptors, Prostaglandin; Retina; Xanthenes; Xanthones | 1994 |
Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity.
Topics: Adenosine Triphosphatases; Animals; Apomorphine; Behavior, Animal; Disease Models, Animal; Electron Transport Complex IV; Electrophoresis, Polyacrylamide Gel; Male; Melatonin; Mitochondria; Motor Activity; NAD; Neuroprotective Agents; Oxidative Phosphorylation; Oxidopamine; Parkinson Disease; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Substantia Nigra | 2001 |
cDNA gene expression profile homology of antioxidants and their antiapoptotic and proapoptotic activities in human neuroblastoma cells.
Topics: Antioxidants; Apomorphine; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspases; Catechin; Cell Survival; Dopamine; Dose-Response Relationship, Drug; Gene Expression Profiling; Gene Expression Regulation; Humans; Melatonin; Neuroblastoma; Oligonucleotide Array Sequence Analysis; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured | 2003 |
Effects of melatonin on behavioral dopaminergic supersensitivity.
Topics: Animals; Apomorphine; Behavior, Animal; Dopamine; Dopamine Agonists; Dopamine Antagonists; Haloperidol; Male; Melatonin; Rats; Rats, Wistar; Time Factors | 2003 |
Gene and protein expression profiles of anti- and pro-apoptotic actions of dopamine, R-apomorphine, green tea polyphenol (-)-epigallocatechine-3-gallate, and melatonin.
Topics: Antioxidants; Apomorphine; Apoptosis; Catechin; Cell Line; Cell Survival; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Gene Expression Profiling; Gene Expression Regulation; Humans; Melatonin; Neuroprotective Agents; Oligonucleotide Array Sequence Analysis | 2003 |
Circadian-dependent effect of melatonin on dopaminergic D2 antagonist-induced hypokinesia and agonist-induced stereotypies in rats.
Topics: Animals; Apomorphine; Circadian Rhythm; Darkness; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Fluphenazine; Hypokinesia; Light; Male; Melatonin; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Stereotyped Behavior | 2004 |
Physiological neuroprotection by melatonin in a 6-hydroxydopamine model of Parkinson's disease.
Topics: Animals; Apomorphine; Brain-Derived Neurotrophic Factor; Densitometry; Dopamine Agonists; Functional Laterality; Glial Cell Line-Derived Neurotrophic Factor; Immunohistochemistry; Male; Melatonin; Neostriatum; Neuroprotective Agents; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Receptor, Melatonin, MT1; Receptors, Melatonin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stereotyped Behavior; Sympatholytics; Tyrosine 3-Monooxygenase | 2006 |
Involvement of dopamine receptors in the antidepressant-like effect of melatonin in the tail suspension test.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antidepressive Agents; Apomorphine; Benzazepines; Dopamine Agonists; Dopamine Antagonists; Drug Synergism; Fluoxetine; Haloperidol; Immobility Response, Tonic; Male; Melatonin; Mice; Motor Activity; Sulpiride | 2010 |
Serum melatonin is an alternative index of Parkinson's disease severity.
Topics: Aged; Aged, 80 and over; Animals; Apomorphine; Biomarkers; Dopamine Agonists; Female; Humans; Male; Melatonin; Middle Aged; Motor Activity; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Time Factors | 2014 |
Electrophysiological characterization of dopamine neuronal activity in the ventral tegmental area across the light-dark cycle.
Topics: Action Potentials; Amphetamine; Animals; Apomorphine; Central Nervous System Depressants; Circadian Rhythm; Dopamine Agonists; Dopamine Uptake Inhibitors; Dopaminergic Neurons; Dose-Response Relationship, Drug; Male; Melatonin; Microelectrodes; Photoperiod; Rats, Sprague-Dawley; Ventral Tegmental Area | 2014 |
[THYMIC HORMONES, ANTIOXIDANT ENZYMES AND NEUROGENESIS OF BULBUS OLFACTORIUS IN RATS WITH PARKINSONISM: THE EFFECT OF MELATONIN].
Topics: Animals; Antioxidants; Apomorphine; Ataxia; Catalase; Cell Count; Cell Differentiation; Dopamine Agonists; Gene Expression; Glutathione Peroxidase; Male; Melatonin; Nestin; Neural Stem Cells; Neuroprotective Agents; Olfactory Bulb; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Wistar; Superoxide Dismutase; Thymic Factor, Circulating; Thymus Gland | 2015 |